Novonix (NVX) Liabilities and Shareholders Equity (2020 - 2025)

Novonix (NVX) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $282.9 million in Q4 2025.

• For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 25.13% year-over-year to $282.9 million; the trailing twelve-month figure through Dec 2025 stood at $1.0 billion (down 2.95% YoY), and the FY2025 full-year result was $282.9 million, up 25.13% from the prior year.
• Liabilities and Shareholders Equity for Q4 2025 stood at $282.9 million, up from $226.1 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $314.8 million in Q2 2022 and bottomed at $156.2 million in Q2 2021.
• The 5-year median for Liabilities and Shareholders Equity is $270.4 million (2022), against an average of $253.5 million.
• The widest annual swing landed in 2021, when Liabilities and Shareholders Equity surged 201.81%; it then declined 14.14% in 2024.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $156.2 million in 2021, then surged by 77.6% to $277.4 million in 2022, then decreased by 5.08% to $263.3 million in 2023, then slipped by 14.14% to $226.1 million in 2024, then rose by 25.13% to $282.9 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $282.9 million (Q4 2025), $226.1 million (Q4 2024), and $263.3 million (Q4 2023), per Business Quant data.

Peer Comparison